Teaching Old Drugs New Tricks in the Fight Against Infectious Diseases

Article

A new article looks at how currently available drugs for various conditions might be repurposed alone or in combination with other drugs to treat infectious diseases. Such a strategy should be pursued in part because the development of new therapeutics and vaccines usually takes a long time with immense resources. In addition, the speed of developing new therapies for drug-resistant pathogens has not kept up with the evolution of drug resistance by these pathogens.

"Historically, drug repurposing for outbreaks of bacterial, viral, and related infections has been an underutilized vehicle for discovery of novel interventions due to the limited potential for commercialization. Thus, involvement of non-profit entities in the discovery process for such unmet needs is crucial," said Dr. Wei Zheng, lead author of the British Journal of Pharmacology study. "To combat global challenges caused by drug-resistant pathogens, a new model of translational research including government, academic researchers, and private drug industry is needed."

Source: Wiley

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content